TY - JOUR AU - Kanarek, M. S. PY - 2011 DA - 2011// TI - Mesothelioma from chrysotile asbestos: update JO - Ann Epidemiol VL - 21 UR - https://doi.org/10.1016/j.annepidem.2011.05.010 DO - 10.1016/j.annepidem.2011.05.010 ID - Kanarek2011 ER - TY - JOUR AU - Robinson, B. W. AU - Lake, R. A. PY - 2005 DA - 2005// TI - Advances in malignant mesothelioma JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMra050152 DO - 10.1056/NEJMra050152 ID - Robinson2005 ER - TY - JOUR AU - Vogelzang, N. J. PY - 2003 DA - 2003// TI - Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.11.136 DO - 10.1200/JCO.2003.11.136 ID - Vogelzang2003 ER - TY - JOUR AU - de Perrot, M. PY - 2008 DA - 2008// TI - Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma JO - Ann Thorac Surg VL - 85 UR - https://doi.org/10.1016/j.athoracsur.2007.11.065 DO - 10.1016/j.athoracsur.2007.11.065 ID - de Perrot2008 ER - TY - JOUR AU - de Perrot, M. PY - 2007 DA - 2007// TI - Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma JO - J Thorac Cardiovasc Surg VL - 133 UR - https://doi.org/10.1016/j.jtcvs.2006.06.044 DO - 10.1016/j.jtcvs.2006.06.044 ID - de Perrot2007 ER - TY - JOUR AU - de Perrot, M. PY - 2009 DA - 2009// TI - Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.17.5604 DO - 10.1200/JCO.2008.17.5604 ID - de Perrot2009 ER - TY - JOUR AU - Ribi, K. PY - 2008 DA - 2008// TI - Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes JO - Lung Cancer VL - 61 UR - https://doi.org/10.1016/j.lungcan.2008.01.013 DO - 10.1016/j.lungcan.2008.01.013 ID - Ribi2008 ER - TY - JOUR AU - Cho, B. C. PY - 2014 DA - 2014// TI - A feasibility study evaluating surgery for mesothelioma after radiation therapy: the "SMART" approach for resectable malignant pleural mesothelioma JO - J Thorac Oncol VL - 9 UR - https://doi.org/10.1097/JTO.0000000000000078 DO - 10.1097/JTO.0000000000000078 ID - Cho2014 ER - TY - JOUR AU - Anraku, M. PY - 2010 DA - 2010// TI - Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma JO - J Immunol VL - 185 UR - https://doi.org/10.4049/jimmunol.0900437 DO - 10.4049/jimmunol.0900437 ID - Anraku2010 ER - TY - JOUR AU - Wu, L. PY - 2011 DA - 2011// TI - Tumor cell repopulation between cycles of chemotherapy is inhibited by regulatory T-cell depletion in a murine mesothelioma model JO - J Thorac Oncol VL - 6 UR - https://doi.org/10.1097/JTO.0b013e3182208ee0 DO - 10.1097/JTO.0b013e3182208ee0 ID - Wu2011 ER - TY - JOUR AU - Wu, L. PY - 2012 DA - 2012// TI - CTLA-4 blockade expands infiltrating T cells and inhibits cancer cell repopulation during the intervals of chemotherapy in murine mesothelioma JO - Mol Cancer Ther VL - 11 UR - https://doi.org/10.1158/1535-7163.MCT-11-1014 DO - 10.1158/1535-7163.MCT-11-1014 ID - Wu2012 ER - TY - JOUR AU - Tagawa, T. PY - 2013 DA - 2013// TI - Antitumor impact of interferon-gamma producing CD1d-restricted NKT cells in murine malignant mesothelioma JO - J Immunother VL - 36 UR - https://doi.org/10.1097/CJI.0b013e3182a801f2 DO - 10.1097/CJI.0b013e3182a801f2 ID - Tagawa2013 ER - TY - JOUR AU - Wu, L. PY - 2014 DA - 2014// TI - Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma JO - Cancer Immunol Immunother VL - 63 UR - https://doi.org/10.1007/s00262-014-1597-9 DO - 10.1007/s00262-014-1597-9 ID - Wu2014 ER - TY - JOUR AU - Wu, L. PY - 2015 DA - 2015// TI - Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model JO - Oncotarget VL - 6 ID - Wu2015 ER - TY - JOUR AU - Licun, W. AU - Tannock, I. F. PY - 2003 DA - 2003// TI - Selective estrogen receptor modulators as inhibitors of repopulation of human breast cancer cell lines after chemotherapy JO - Clin Cancer Res VL - 9 ID - Licun2003 ER - TY - JOUR AU - Wu, L. AU - Tannock, I. F. PY - 2003 DA - 2003// TI - Repopulation in murine breast tumors during and after sequential treatments with cyclophosphamide and 5-fluorouracil JO - Cancer Res VL - 63 ID - Wu2003 ER - TY - JOUR AU - Fung, A. S. AU - Wu, L. AU - Tannock, I. F. PY - 2009 DA - 2009// TI - Concurrent and sequential administration of chemotherapy and the mammalian target of rapamycin inhibitor temsirolimus in human cancer cells and xenografts JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-3007 DO - 10.1158/1078-0432.CCR-08-3007 ID - Fung2009 ER - TY - JOUR AU - Wu, L. AU - Tannock, I. F. PY - 2005 DA - 2005// TI - Effect of the selective estrogen receptor modulator arzoxifene on repopulation of hormone-responsive breast cancer xenografts between courses of chemotherapy JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-1258 DO - 10.1158/1078-0432.CCR-05-1258 ID - Wu2005 ER - TY - JOUR AU - Wu, L. AU - Birle, D. C. AU - Tannock, I. F. PY - 2005 DA - 2005// TI - Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-3137 DO - 10.1158/0008-5472.CAN-04-3137 ID - Wu2005 ER - TY - JOUR AU - Hovden, A. O. AU - Appel, S. PY - 2010 DA - 2010// TI - The first dendritic cell-based therapeutic cancer vaccine is approved by the FDA JO - Scand J Immunol VL - 72 UR - https://doi.org/10.1111/j.1365-3083.2010.02464.x DO - 10.1111/j.1365-3083.2010.02464.x ID - Hovden2010 ER - TY - JOUR AU - Prashad, S. L. PY - 2015 DA - 2015// TI - GPI-80 defines self-renewal ability in hematopoietic stem cells during human development JO - Cell Stem Cell VL - 16 UR - https://doi.org/10.1016/j.stem.2014.10.020 DO - 10.1016/j.stem.2014.10.020 ID - Prashad2015 ER - TY - JOUR AU - Pasdar, E. A. PY - 2015 DA - 2015// TI - Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0119549 DO - 10.1371/journal.pone.0119549 ID - Pasdar2015 ER - TY - STD TI - Dotse E, Bian Y. Isolation of colorectal cancer stem-like cells. Cytotechnology. 2014;68(4):609–619. ID - ref23 ER - TY - JOUR AU - Hotta, A. PY - 2009 DA - 2009// TI - EOS lentiviral vector selection system for human induced pluripotent stem cells JO - Nat Protoc VL - 4 UR - https://doi.org/10.1038/nprot.2009.201 DO - 10.1038/nprot.2009.201 ID - Hotta2009 ER - TY - JOUR AU - Blum, W. PY - 2017 DA - 2017// TI - Stem cell factor-based identification and functional properties of in vitro-selected subpopulations of malignant mesothelioma cells JO - Stem Cell Reports VL - 8 UR - https://doi.org/10.1016/j.stemcr.2017.02.005 DO - 10.1016/j.stemcr.2017.02.005 ID - Blum2017 ER - TY - JOUR AU - Shahryari, A. PY - 2014 DA - 2014// TI - Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma JO - Stem Cells VL - 32 UR - https://doi.org/10.1002/stem.1542 DO - 10.1002/stem.1542 ID - Shahryari2014 ER - TY - JOUR AU - Blum, W. PY - 2015 DA - 2015// TI - Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line JO - In Vitro Cell Dev Biol Anim VL - 51 UR - https://doi.org/10.1007/s11626-015-9885-z DO - 10.1007/s11626-015-9885-z ID - Blum2015 ER - TY - JOUR AU - Thieke, C. PY - 2015 DA - 2015// TI - Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy JO - Radiat Oncol VL - 10 UR - https://doi.org/10.1186/s13014-015-0575-5 DO - 10.1186/s13014-015-0575-5 ID - Thieke2015 ER - TY - JOUR AU - de Perrot, M. PY - 2016 DA - 2016// TI - Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma JO - J Thorac Cardiovasc Surg VL - 151 UR - https://doi.org/10.1016/j.jtcvs.2015.09.129 DO - 10.1016/j.jtcvs.2015.09.129 ID - de Perrot2016 ER - TY - JOUR AU - Wu, L. PY - 2017 DA - 2017// TI - Patient-derived xenograft establishment from human malignant pleural mesothelioma JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-0844 DO - 10.1158/1078-0432.CCR-16-0844 ID - Wu2017 ER - TY - JOUR AU - Guazzelli, A. PY - 2015 DA - 2015// TI - Tremelimumab for the treatment of malignant mesothelioma JO - Expert Opin Biol Ther VL - 15 UR - https://doi.org/10.1517/14712598.2015.1116515 DO - 10.1517/14712598.2015.1116515 ID - Guazzelli2015 ER - TY - STD TI - A Potential Immune Therapy for Mesothelioma. Cancer Discov. 2015;5(7):OF14. https://doi.org/10.1158/2159-8290.CD-NB2015-067. Epub 2015 May 8. PMID: 25956959 ID - ref32 ER - TY - STD TI - De La Maza L, Wu M, Wu L, Yun H, Zhao Y, Cattral M, McCart A, Cho BJ, de Perrot M. In Situ Vaccination after Accelerated Hypofractionated Radiation and Surgery in a Mesothelioma Mouse Model. Clin Cancer Res. 2017;23(18):5502–5513. ID - ref33 ER - TY - JOUR AU - Tannock, I. F. PY - 2015 DA - 2015// TI - Cancer: resistance through repopulation JO - Nature VL - 517 UR - https://doi.org/10.1038/nature14075 DO - 10.1038/nature14075 ID - Tannock2015 ER - TY - JOUR AU - Saggar, J. K. AU - Tannock, I. F. PY - 2015 DA - 2015// TI - Chemotherapy rescues hypoxic tumor cells and induces their Reoxygenation and repopulation-an effect that is inhibited by the hypoxia-activated prodrug TH-302 JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-2298 DO - 10.1158/1078-0432.CCR-14-2298 ID - Saggar2015 ER - TY - STD TI - Zhao Q, et al. Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: from patients to patient-derived tumor xenograft models. Oncotarget. 2016;7(30):47431–47443. ID - ref36 ER - TY - JOUR AU - Zhou, F. PY - 2016 DA - 2016// TI - Tracing haematopoietic stem cell formation at single-cell resolution JO - Nature VL - 533 UR - https://doi.org/10.1038/nature17997 DO - 10.1038/nature17997 ID - Zhou2016 ER - TY - JOUR AU - Shigeishi, H. PY - 2013 DA - 2013// TI - Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3beta influenced by CD44 and RHAMM JO - Stem Cells VL - 31 UR - https://doi.org/10.1002/stem.1418 DO - 10.1002/stem.1418 ID - Shigeishi2013 ER - TY - JOUR AU - Wang, J. PY - 2006 DA - 2006// TI - A protein interaction network for pluripotency of embryonic stem cells JO - Nature VL - 444 UR - https://doi.org/10.1038/nature05284 DO - 10.1038/nature05284 ID - Wang2006 ER - TY - JOUR AU - Boyer, L. A. PY - 2005 DA - 2005// TI - Core transcriptional regulatory circuitry in human embryonic stem cells JO - Cell VL - 122 UR - https://doi.org/10.1016/j.cell.2005.08.020 DO - 10.1016/j.cell.2005.08.020 ID - Boyer2005 ER - TY - JOUR AU - Woltjen, K. PY - 2009 DA - 2009// TI - piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells JO - Nature VL - 458 UR - https://doi.org/10.1038/nature07863 DO - 10.1038/nature07863 ID - Woltjen2009 ER - TY - JOUR AU - Ovchinnikov, D. A. PY - 2014 DA - 2014// TI - Transgenic human ES and iPS reporter cell lines for identification and selection of pluripotent stem cells in vitro JO - Stem Cell Res VL - 13 UR - https://doi.org/10.1016/j.scr.2014.05.006 DO - 10.1016/j.scr.2014.05.006 ID - Ovchinnikov2014 ER - TY - JOUR AU - Shinde, V. PY - 2016 DA - 2016// TI - Simulated microgravity modulates differentiation processes of embryonic stem cells JO - Cell Physiol Biochem VL - 38 UR - https://doi.org/10.1159/000443090 DO - 10.1159/000443090 ID - Shinde2016 ER - TY - JOUR AU - Chen, W. PY - 2008 DA - 2008// TI - Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells JO - Cancer Cell VL - 13 UR - https://doi.org/10.1016/j.ccr.2008.03.005 DO - 10.1016/j.ccr.2008.03.005 ID - Chen2008 ER - TY - JOUR AU - Kratky, W. PY - 2011 DA - 2011// TI - Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1108945108 DO - 10.1073/pnas.1108945108 ID - Kratky2011 ER - TY - JOUR AU - Carreno, B. M. PY - 2013 DA - 2013// TI - IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity JO - J Clin Invest VL - 123 UR - https://doi.org/10.1172/JCI68395 DO - 10.1172/JCI68395 ID - Carreno2013 ER - TY - JOUR AU - Voest, E. E. PY - 1995 DA - 1995// TI - Inhibition of angiogenesis in vivo by interleukin 12 JO - J Natl Cancer Inst VL - 87 UR - https://doi.org/10.1093/jnci/87.8.581 DO - 10.1093/jnci/87.8.581 ID - Voest1995 ER - TY - JOUR AU - Nguyen, S. T. PY - 2015 DA - 2015// TI - Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations JO - Onco Targets Ther VL - 8 ID - Nguyen2015 ER - TY - JOUR AU - Kotini, A. G. PY - 2017 DA - 2017// TI - Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia JO - Cell Stem Cell VL - 20 UR - https://doi.org/10.1016/j.stem.2017.01.009 DO - 10.1016/j.stem.2017.01.009 ID - Kotini2017 ER - TY - JOUR AU - Lynn, R. C. PY - 2016 DA - 2016// TI - High-affinity FRbeta-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity JO - Leukemia VL - 30 UR - https://doi.org/10.1038/leu.2016.35 DO - 10.1038/leu.2016.35 ID - Lynn2016 ER -